Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancer

• Published in: Journal of gastrointestinal oncology Vol. 7; no. 4; pp. 547 - 555
• Main Authors: Mellon, Eric A, Strom, Tobin J, Hoffe, Sarah E, Frakes, Jessica M, Springett, Gregory M, Hodul, Pamela J, Malafa, Mokenge P, Chuong, Michael D, Shridhar, Ravi
• Format: Journal Article
• Language: English
• Published: China AME Publishing Company 01.08.2016
• Subjects: Original; Radiotherapy; pancreatic neoplasms; neoadjuvant therapy

Neoadjuvant multi-agent chemotherapy and stereotactic body radiation therapy (SBRT) are utilized to increase margin negative (R0) resection rates in borderline resectable pancreatic cancer (BRPC) or locally advanced pancreatic cancer (LAPC) patients. Concerns persist that these neoadjuvant therapies...